Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 898 clinical trials
featured
TRANSFORM – B cell non-Hodgkin lymphoma - JCAR017-BCM-003 - US  

) aggressive Non-Hodgkin lymphoma (NHL) to compare safety and efficacy between the standard of care (SOC) strategy versus JCAR017 (also known as lisocabtagene maraleucel or liso-cel). Subjects will be randomized

  • 2946 views
  • 05 Jan, 2021
  • 10 locations
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL

  • 1875 views
  • 17 Feb, 2021
  • 15 locations
featured
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

  • 590 views
  • 23 Nov, 2020
  • 5 locations
featured
TRANSCEND - Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - TRANSCEND-CLL-004 - US Spanish  

Phase 2 single-arm, multi-cohort study to determine the efficacy and safety of JCAR017 (autologous T cells expressing anti-CD19 chimeric antigen receptor) in adult subjects with aggressive B-NHL

  • 268 views
  • 19 Jan, 2021
  • 16 locations
featured
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Patients With Follicular Non-Hodgkin’s Lymphoma

This is a multi-center Phase 1/2 open label trial of intratumoral G100 in patients with low grade NHL. Patients with NHL will be enrolled and receive G100 to an accessable tumor mass. Clinical

lymphomas
non-hodgkin's lymphoma
lymphoma
  • 73 views
  • 22 Dec, 2020
  • 31 locations
featured
Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (C/SLL) or Non-Hodgkin Lymphoma (NHL)

People with previously treated Lymphomas are asked to participate in a research study being conducted by Northwell Health.  

  • 17 views
  • 23 Jul, 2020
  • 1 location
featured
Diffuse Large B Cell/Non-Hodgkin Lymphoma

Diffuse Large B Cell/Non-Hodgkin Lymphoma

  • 902 views
  • 08 Nov, 2020
  • 1 location
featured
PILOT - B cell non-Hodgkin lymphoma - TRANSCEND-PILOT-017006 - US  

single line of immunochemotherapy for aggressive B-cell non-Hodgkin lymphoma (NHL) and are ineligible for hematopoietic stem cell transplant (based on age, performance status, and/or comorbidities

  • 2758 views
  • 15 Dec, 2020
  • 12 locations
featured
ANHL04B1: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma

ANHL04B1: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin Lymphoma

  • 34 views
  • 08 Nov, 2020
  • 1 location
featured
A safety and Tolerability Study of INCB053915 in Combination With INCB050465 in Diffuse Large B-Cell Lymphoma

The purpose of this study is to evaluate the safety and tolerability of INCB053914 in combination with INCB050465 in relapsed or refractory Diffuse Large B-Cell Lymphoma (DLBCL).  

b-cell lymphoma
lymphomas
lymphoma
  • 45 views
  • 14 Dec, 2020
  • 5 locations